NASDAQ:MGLN - Magellan Health Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$95.45 +0.10 (+0.10 %)
(As of 07/20/2018 04:17 AM ET)
Previous Close$95.35
Today's Range$94.20 - $96.70
52-Week Range$71.75 - $112.25
Volume479,200 shs
Average Volume188,040 shs
Market Capitalization$2.34 billion
P/E Ratio17.35
Dividend YieldN/A
Beta0.54
Magellan Health logoMagellan Health, Inc. provides healthcare management services in the United States. It operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine for health plans, care organizations, and employers. It also contracts with local, state, and federal governmental agencies to provide services to recipients under Medicaid, Medicare, and other government programs, such as behavioral health and EAP, as well as healthcare management and long term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. This segment offers pharmacy benefit management services, pharmacy benefit administration for state Medicaid and other government sponsored programs, pharmaceutical dispensing services, clinical and formulary management programs, medical pharmacy management programs, and programs for the integrated management of specialty drugs that treat complex conditions. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, and third party administrators. Magellan Health, Inc. was founded in 1969 and is headquartered in Scottsdale, Arizona.

Receive MGLN News and Ratings via Email

Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Hospitals
Sub-IndustryManaged Health Care
SectorMedical
SymbolNASDAQ:MGLN
CUSIP55907920
Phone602-572-6050

Debt

Debt-to-Equity Ratio0.56
Current Ratio1.64
Quick Ratio1.60

Price-To-Earnings

Trailing P/E Ratio17.35
Forward P/E Ratio17.45
P/E Growth1.12

Sales & Book Value

Annual Sales$5.84 billion
Price / Sales0.40
Cash Flow$10.6292 per share
Price / Cash8.98
Book Value$53.09 per share
Price / Book1.80

Profitability

EPS (Most Recent Fiscal Year)$5.50
Net Income$110.20 million
Net Margins1.64%
Return on Equity10.72%
Return on Assets4.73%

Miscellaneous

Employees10,700
Outstanding Shares24,630,000
Market Cap$2,337.12

Magellan Health (NASDAQ:MGLN) Frequently Asked Questions

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

How were Magellan Health's earnings last quarter?

Magellan Health (NASDAQ:MGLN) announced its quarterly earnings results on Thursday, April, 26th. The company reported $0.81 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by $0.20. The company had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.83 billion. Magellan Health had a return on equity of 10.72% and a net margin of 1.64%. The firm's quarterly revenue was up 38.3% on a year-over-year basis. During the same quarter last year, the company posted $1.09 earnings per share. View Magellan Health's Earnings History.

When is Magellan Health's next earnings date?

Magellan Health is scheduled to release their next quarterly earnings announcement on Friday, July, 27th 2018. View Earnings Estimates for Magellan Health.

What guidance has Magellan Health issued on next quarter's earnings?

Magellan Health updated its FY18 earnings guidance on Thursday, April, 26th. The company provided EPS guidance of $5.90-6.68 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.73. The company issued revenue guidance of $7.5-7.8 billion, compared to the consensus revenue estimate of $7.66 billion.

What price target have analysts set for MGLN?

4 Wall Street analysts have issued 1-year price targets for Magellan Health's stock. Their predictions range from $94.00 to $105.00. On average, they anticipate Magellan Health's share price to reach $99.50 in the next twelve months. This suggests a possible upside of 4.2% from the stock's current price. View Analyst Ratings for Magellan Health.

What is the consensus analysts' recommendation for Magellan Health?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Magellan Health's key competitors?

Who are Magellan Health's key executives?

Magellan Health's management team includes the folowing people:
  • Mr. Barry Morgan Smith, Chairman & CEO (Age 64)
  • Mr. Jonathan N. Rubin, Chief Financial Officer (Age 54)
  • Mr. Daniel N. Gregoire, Gen. Counsel & Sec. (Age 62)
  • Mr. Sanjeev K. Srivastava, Chief Exec. Officer of Magellan Healthcare (Age 51)
  • Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 37)

Has Magellan Health been receiving favorable news coverage?

News headlines about MGLN stock have been trending positive this week, Accern Sentiment reports. The research group scores the sentiment of news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Magellan Health earned a daily sentiment score of 0.26 on Accern's scale. They also assigned news headlines about the company an impact score of 46.64 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

Who are Magellan Health's major shareholders?

Magellan Health's stock is owned by many different of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (2.72%), Smith Graham & Co. Investment Advisors LP (0.55%), Bank of Montreal Can (0.41%), Peregrine Capital Management LLC (0.41%), Cambiar Investors LLC (0.17%) and DnB Asset Management AS (0.16%). Company insiders that own Magellan Health stock include Barry M Smith, Clapper Caskie Lewis, Daniel N Gregoire, Eran Broshy, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Institutional Ownership Trends for Magellan Health.

Which major investors are selling Magellan Health stock?

MGLN stock was sold by a variety of institutional investors in the last quarter, including DnB Asset Management AS, James Investment Research Inc., Bank of Montreal Can, Fisher Asset Management LLC, Smith Graham & Co. Investment Advisors LP and Municipal Employees Retirement System of Michigan. Company insiders that have sold Magellan Health company stock in the last year include Barry M Smith, Clapper Caskie Lewis, Daniel N Gregoire, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Insider Buying and Selling for Magellan Health.

Which major investors are buying Magellan Health stock?

MGLN stock was purchased by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, Peregrine Capital Management LLC, Alpha Windward LLC and Assenagon Asset Management S.A.. View Insider Buying and Selling for Magellan Health.

How do I buy shares of Magellan Health?

Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Magellan Health's stock price today?

One share of MGLN stock can currently be purchased for approximately $95.45.

How big of a company is Magellan Health?

Magellan Health has a market capitalization of $2.34 billion and generates $5.84 billion in revenue each year. The company earns $110.20 million in net income (profit) each year or $5.50 on an earnings per share basis. Magellan Health employs 10,700 workers across the globe.

How can I contact Magellan Health?

Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected]


MarketBeat Community Rating for Magellan Health (NASDAQ MGLN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  244 (Vote Outperform)
Underperform Votes:  236 (Vote Underperform)
Total Votes:  480
MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe MGLN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MGLN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.